Table 5.
Discrimnant validity of two questionnaires(univariate and multivariate analysis using 25 th percentile for ADD and SC)
| |
|
n |
GOHAI |
OHIP-14 |
||
|---|---|---|---|---|---|---|
| ADD<44 | SC<9 | ADD<60 | SC<13 | |||
| |
≤45 |
55 |
15(27.3%) |
19(34.5%) |
14(25.5%) |
11(20%) |
| Age |
45-65 |
192 |
61(31.8%) |
68(35.4%) |
56(29.2%) |
36(18.8%) |
| |
>65 |
103 |
25(24.3%) |
33(32%) |
24(23.3%) |
16(15.5%) |
| |
Reference |
|
— — — |
— — — |
— — — |
— — — |
| ORCrude(95%CI) |
A1 |
|
1.08(0.46;2.54) |
0.97(0.44;2.16) |
1.15(0.47;2.81) |
1.72(0.65;4.69) |
| |
A2 |
|
1.37(0.74;2.53) |
1.04(0.58;1.84) |
1.43(0.76;2.69) |
1.47(0.71;3.08) |
| |
Reference |
|
— — — |
— — — |
— — — |
— — — |
| ORadjusted(95%CI) |
A1 |
|
— — — |
— — — |
— — — |
— — — |
| |
A2 |
|
— — — |
— — — |
— — — |
— — — |
| Sex |
Male |
86 |
20(23.3%) |
25(29.1%) |
19(22.1%) |
10(11.6%) |
| |
Female |
264 |
81(30.7%) |
95(36%) |
75(28.4%) |
53(20.1%) |
| ORCrude(95%CI) |
|
|
1.36(0.75;2.46) |
1.24(0.71;2.15) |
1.20(0.65;2.21) |
1.72(0.63;3.27) |
| ORadjusted(95%CI) |
|
|
— — — |
— — — |
— — — |
— — — |
| Xerostomia |
Yes |
134 |
41(30.6%) |
53(39.6%) |
46(34.3%)ǂ |
31(23.1%)ǂ |
| |
No |
215 |
59(27.4%) |
66(30.7%) |
48(22.3%)ǂ |
32(14.9%)ǂ |
| ORCrude(95%CI) |
|
|
0.99(0.59;1.67) |
0.75(0.46;1.22) |
0.49(0.29;0.85) |
0.61(0.33;1.12) |
| ORadjusted(95%CI) |
|
|
— — — |
— — — |
0.49(0.29;0.84) |
— — — |
| |
Partial denture |
30 |
12(40%) |
12(40%) |
12(40%) |
6(20%) |
| Prosthesis |
Complete denture |
122 |
32(26.2%) |
38(31.1%) |
31(25.4%) |
23(18.9%) |
| |
With out denture |
198 |
57(28.8%) |
70(35.4%) |
51(25.8%) |
34(17.2%) |
| |
Reference |
|
— — — |
— — — |
— — — |
— — — |
| ORCrude(95%CI) |
P1 |
|
1.70(0.74;3.91) |
1.24(0.54;2.81) |
2.30(0.99;5.33) |
1.39(0.51;3.82) |
| |
P2 |
|
0.93(0.51;1.68) |
0.77(0.44;1.36) |
1.06(0.57;1.97) |
1.25(0.62;2.53) |
| |
Reference |
|
— — — |
— — — |
— — — |
— — — |
| ORadjusted(95%CI) |
P1 |
|
— — — |
— — — |
— — — |
— — — |
| |
P2 |
|
— — — |
— — — |
— — — |
— — — |
| type of anti- |
Oral intake |
240 |
59(24.6%)# |
72(30%)ǂ |
53(22.1%)# |
32(13.3%)# |
| diabetic medication |
Inject insulin |
110 |
42(38.2%)# |
48(43.6%)ǂ |
41(37.3%)# |
31(28.2%)# |
| ORCrude(95%CI) |
|
|
2.28(1.33;3.89) |
1.99(1.19;3.32) |
2.44(1.40;4.26) |
2.60(1.41;4.80) |
| ORadjusted(95%CI) |
|
|
1.92(1.18;3.13) |
1.83(1.14;2.92) |
2.12(1.27;3.54) |
2.39(1.36;4.20) |
| HbA1C |
≤7 |
103 |
27(26.2%) |
32(31.1%) |
30(29.1%) |
18(17.5%) |
| |
>7 |
247 |
74(30%) |
88(35.6%) |
64(25.9%) |
45(18.2%) |
| ORCrude(95%CI) |
|
|
0.84(0.47;1.49) |
0.89(0.51;1.55) |
1.72(0.95;3.11) |
1.43(0.72;2.85) |
| ORadjusted(95%CI) |
|
|
— — — |
— — — |
1.82(1.02;3.25) |
— — — |
| Diabetes |
≤10 |
246 |
75(30.5%) |
87(35.4%) |
67(27.2%) |
42(17.1%) |
| Duration |
>10 |
104 |
26(25%) |
33(31.7%) |
27(26%) |
21(20.2%) |
| ORCrude(95%CI) |
|
|
1.82(1.01;3.26) |
1.51(0.87;2.60) |
1.44(0.79;2.62) |
1.12(0.58;2.17) |
| ORadjusted(95%CI) | — — — | — — — | — — — | — — — | ||
ǂ P < 0.05.
# p < 0.001.